CN106344435A - 消除妊娠纹的护肤膏 - Google Patents
消除妊娠纹的护肤膏 Download PDFInfo
- Publication number
- CN106344435A CN106344435A CN201610738211.4A CN201610738211A CN106344435A CN 106344435 A CN106344435 A CN 106344435A CN 201610738211 A CN201610738211 A CN 201610738211A CN 106344435 A CN106344435 A CN 106344435A
- Authority
- CN
- China
- Prior art keywords
- parts
- striae gravidarum
- cold cream
- skin
- eliminating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010040925 Skin striae Diseases 0.000 title claims abstract description 59
- 239000006071 cream Substances 0.000 title abstract description 7
- 102000008186 Collagen Human genes 0.000 claims abstract description 28
- 108010035532 Collagen Proteins 0.000 claims abstract description 28
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims abstract description 18
- 229930002330 retinoic acid Natural products 0.000 claims abstract description 18
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 claims abstract description 16
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims abstract description 11
- 229940009098 aspartate Drugs 0.000 claims abstract description 11
- 230000010261 cell growth Effects 0.000 claims abstract description 11
- 239000003102 growth factor Substances 0.000 claims abstract description 10
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 claims abstract description 8
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000008777 kaempferol Nutrition 0.000 claims abstract description 8
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 claims abstract description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 33
- 239000008294 cold cream Substances 0.000 claims description 28
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 16
- 229960001727 tretinoin Drugs 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 11
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 claims description 11
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 claims description 11
- UIUXUFNYAYAMOE-UHFFFAOYSA-N methylsilane Chemical compound [SiH3]C UIUXUFNYAYAMOE-UHFFFAOYSA-N 0.000 claims description 11
- 239000000230 xanthan gum Substances 0.000 claims description 11
- 229920001285 xanthan gum Polymers 0.000 claims description 11
- 229940082509 xanthan gum Drugs 0.000 claims description 11
- 235000010493 xanthan gum Nutrition 0.000 claims description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 229960005070 ascorbic acid Drugs 0.000 claims description 10
- 150000002148 esters Chemical class 0.000 claims description 10
- 229960004275 glycolic acid Drugs 0.000 claims description 10
- 229940088594 vitamin Drugs 0.000 claims description 10
- 229930003231 vitamin Natural products 0.000 claims description 10
- 235000013343 vitamin Nutrition 0.000 claims description 10
- 239000011782 vitamin Substances 0.000 claims description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 10
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 3
- 230000012010 growth Effects 0.000 claims description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims 2
- 229960002591 hydroxyproline Drugs 0.000 claims 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims 2
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 229920001436 collagen Polymers 0.000 abstract description 13
- NXTGWOGJZSSREB-HJXLNUONSA-N C[SiH2]O.O[C@H]1CN[C@H](C(O)=O)C1 Chemical compound C[SiH2]O.O[C@H]1CN[C@H](C(O)=O)C1 NXTGWOGJZSSREB-HJXLNUONSA-N 0.000 abstract 1
- 210000001339 epidermal cell Anatomy 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 22
- 230000000694 effects Effects 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 9
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- 230000035606 childbirth Effects 0.000 description 7
- 230000037303 wrinkles Effects 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 210000004927 skin cell Anatomy 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 210000002808 connective tissue Anatomy 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 230000003328 fibroblastic effect Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 150000004780 naphthols Chemical class 0.000 description 4
- 239000003016 pheromone Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 210000000589 cicatrix Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 210000002443 helper t lymphocyte Anatomy 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- -1 proline ester Chemical class 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 101001018064 Homo sapiens Lysosomal-trafficking regulator Proteins 0.000 description 1
- 102100033472 Lysosomal-trafficking regulator Human genes 0.000 description 1
- 244000038561 Modiola caroliniana Species 0.000 description 1
- 235000010703 Modiola caroliniana Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 210000000264 venule Anatomy 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Abstract
本发明提供了一种消除妊娠纹的护肤膏,其特征在于,包含以下重量份数的原料:表皮细胞生长因子10‑15份,山萘酚10‑15份,甲基硅烷醇羟脯氨酸酯天冬氨酸酯5‑10份,维生素A酸5‑10份,胶原蛋白10‑15份。本发明能够使妊娠纹淡化消除,且缩短治疗时间。
Description
【技术领域】
本发明涉及日化用品及美容用品领域,尤其涉及一种消除妊娠纹的护肤膏。
【背景技术】
妊娠纹,是萎缩纹的一种,常出现在产后妈妈腹壁、大腿内外侧、臀部、胸部、后腰部及手臂等处。女性在妊娠期,由于荷尔蒙的影响,加之腹部膨隆使皮肤的弹力纤维与胶原纤维损伤或断裂,腹部皮肤变薄变细,出现一些宽窄不同、长短不一的粉红色或紫红色的波浪状花纹,此即未成熟妊娠纹或炎性妊娠纹。分娩后,随着时间推移,这些花纹逐渐消失,但会留下白色或银白色的有光泽的瘢痕线纹,此即成熟妊娠纹。妊娠纹一旦出现,就不会自行消失,严重影响产后女性的体态和身心健康,影响女性的社交和生活。
目前,常见的消除妊娠纹的方法主要包括:(1)精油或膏霜按摩或仪器辅助治疗的方法:精油得到渗透效果好,但是没有很好的修复效果,经过一年的修复,效果能达到40%左右,操作时间长;目前的膏霜只能淡化,且疗程长,效果还不理想;(2)激光疗法:这种方法不适合大面积治疗,且前期能看到效果,后期则没有变化,还对操作技术要求很高,成本高,效果不理想;(3)换肤法,使用化学脱皮剂,多使用酸性或腐蚀性物质,过程中患者痛苦,还易引发增殖疤痕产生,皮肤薄且敏感的皮肤50%会引发增殖疤痕,大面积使用对身体有不良影响,皮肤细胞受损,影响新陈代谢,化学物质产生沉淀还会引发皮肤色素沉淀;(4)注射碱性纤维生长银子,它是促进肉芽增生的过程(一般用于面部填充),填充本身维持时间短,技术不宜掌握,费用大,能修复到60%左右;(5)磨削法:物理磨削皮肤过程痛苦且易留疤痕。
综上可见,目前消除妊娠纹的产品和方法都不理想,有待于进一步的研究和改进。
【发明内容】
针对现有技术的上述缺陷,本发明提供了一种消除妊娠纹的护肤膏,能够使妊娠纹淡化消除,且缩短治疗时间。
本发明的技术方案是:
一种消除妊娠纹的护肤膏,其特征在于,包含以下重量份数的原料:表皮细胞生长因子10-15份,山萘酚10-15份,甲基硅烷醇轻脯氨酸酯天冬氨酸酯5-10份,维生素A酸5-10份,胶原蛋白10-15份。
进一步优选的,上述护肤膏包含以下重量份数的原料:表皮细胞生长因子10-12份,山萘酚10-12份,甲基硅烷醇轻脯氨酸酯天冬氨酸酯8-10份,维生素A酸8-10份,胶原蛋白12-15份。
以上技术方案中,表皮细胞生长因子可刺激上皮细胞和内皮细胞生长,使新的表皮细胞不断长成,将死皮层推动并逐渐脱落,保持肌肤细嫩光滑,同时促进皮肤各种细胞的新陈代谢,增强细胞吸收营养物质,促使胶原及胶原酶合成,分泌胶原物质、透明质酸和糖蛋白,调节胶原纤维,具有滋润皮肤、增强皮肤弹性,减少皮肤皱纹和防止皮肤衰老的作用;山萘酚可以对信息素的传导通道进行调控,而甲基硅烷醇轻脯氨酸酯天冬氨酸酯在信息素的中介作用下,在表皮——真皮结合部的层面上诱导和调节成纤维细胞的增殖,使新纤维的质量接近于旧的纤维,使妊娠纹变淡甚至消除;维A酸是体内维生素A的代谢中间产物,表皮角质形成细胞、黑色素细胞及真皮成纤维细胞都是维A酸作用重要的靶细胞,当皮肤发生生理性老化、或受药物、紫外线辐射及创伤伤害时,维A酸可纠正或预防有害因素对真皮结缔组织生化成分及形态结构引起的异常,刺激皮肤细胞外基质蛋白合成,在真皮上部加速形成新的结缔组织带,并可提高伤口部位的张力强度,促进妊娠纹的改善;胶原蛋白能直接渗入肌肤底层,且与周围组织的亲和性好,可协助细胞制造成胶原蛋白,促使皮肤细胞正常成长,保持角质层水分及纤维结构的完整性,改善皮肤细胞生存环境和促进皮肤组织的新陈代谢,增强血液循环。技术方案中的组分配比是各组分能够稳定混合并发挥药理功效的范围,能够帮助结缔组织的重建和修复促进成纤维细胞的增殖和胶原蛋白的生成。
进一步的,上述护肤膏还包括以下重量份数的原料:维生素C 3-5份,维生素E 3-5份,羟甲基纤维素钠3-5份,丙三醇10-15份,黄原胶1-3份,羟基乙酸3-5份。这些成分一是可以提供必要的营养成分,二则可以形成稳定的膏剂,三则可以使有药理作用的成分充分发挥其作用。
进一步的,上述护肤膏还包括以下重量份数的原料:薰衣草精油1-5份,薄荷冰1-5份,具有镇痛、舒缓的效果。
进一步的,上述维生素A酸为全反式维生素A酸,对成纤维细胞的作用效果更为有效。
进一步的,上述胶原蛋白为水解胶原蛋白,分子量比较小,容易渗透,有利于吸收进入细胞内部。
本发明具有以下有益的技术效果:1)本发明的山萘酚可以对信息素的传导通道进行调控,而甲基硅烷醇轻脯氨酸酯天冬氨酸酯在信息素的中介作用下,在表皮——真皮结合部的层面上诱导和调节成纤维细胞的增殖,使新纤维的质量接近于旧的纤维,使妊娠纹变淡甚至消除;2)本发明的维A酸可纠正或预防有害因素对真皮结缔组织生化成分及形态结构引起的异常,定向靶向受损的成纤维细胞,刺激皮肤细胞外基质蛋白合成,在真皮上部加速形成新的结缔组织带,并可提高伤口部位的张力强度,促进妊娠纹的改善;3)本发明的表皮细胞生长因子可时促进皮肤各种细胞的新陈代谢,增强细胞吸收营养物质,促使胶原及胶原酶合成,分泌胶原物质、透明质酸和糖蛋白,调节胶原纤维,具有滋润皮肤、增强皮肤弹性,促进妊娠纹的淡化;4)本发明的胶原蛋白能直接渗入肌肤底层,且与周围组织的亲和性好,可协助细胞制造成胶原蛋白,促使皮肤细胞正常成长,保持角质层水分及纤维结构的完整性,改善妊娠纹;5)本发明的各个组分通过协同配合,通过各个途径同时作用于导致妊娠纹的各个因素,治疗时间短,治疗效果比较理想;6)本发明的相关组分用于皮肤局部没有任何毒副作用,在任何人体试验中都没有不良反应的报道,使用方式安全无痛感。
【具体实施方式】
以下结合具体实施例,对本发明做进一步描述。
以下所提供的实施例并非用以限制本发明所涵盖的范围,所描述的步骤也不是用以限制其执行顺序。本领域技术人员结合现有公知常识对本发明做显而易见的改进,亦落入本发明要求的保护范围之内。
实施例一
一种消除妊娠纹的护肤膏,包含以下重量份数的原料:表皮细胞生长因子10份,山萘酚10份,甲基硅烷醇轻脯氨酸酯天冬氨酸酯5份,维生素A酸5份,胶原蛋白10份,维生素C3份,维生素E 3份,羟甲基纤维素钠3份,丙三醇10份,黄原胶1份,羟基乙酸3份,薰衣草精油1份,薄荷冰1份。
以上产品经临床150名受试者使用,受试者选取分娩后3月-36月的女性,于早晚各使用一次,使用方法为将0.5克护肤膏均匀涂抹在妊娠纹或皮肤皱纹处,一个月为一疗程。其中,33个受试者使用一个疗程后基本消除了妊娠纹,98个受试者使用六个疗程后基本消除了妊娠纹,11个受试者使用十二个疗程后基本消除了妊娠纹,4个受试者使用十二个疗程后减轻了妊娠纹,其余4个未完成试验。
实施例二
一种消除妊娠纹的护肤膏,包含以下重量份数的原料:表皮细胞生长因子15份,山萘酚15份,甲基硅烷醇轻脯氨酸酯天冬氨酸酯10份,全反式维生素A酸10份,胶原蛋白15份,维生素C 5份,维生素E 5份,羟甲基纤维素钠5份,丙三醇15份,黄原胶3份,羟基乙酸5份,薰衣草精油5份,薄荷冰5份。
实施例三
一种消除妊娠纹的护肤膏,包含以下重量份数的原料:表皮细胞生长因子11份,山萘酚11份,甲基硅烷醇轻脯氨酸酯天冬氨酸酯8份,维生素A酸8份,水解胶原蛋白12份(分子量小于3000道尔顿),维生素C 4份,维生素E 4份,羟甲基纤维素钠4份,丙三醇12份,黄原胶2份,羟基乙酸4份,薰衣草精油3份。
实施例四
一种消除妊娠纹的护肤膏,包含以下重量份数的原料:表皮细胞生长因子12份,山萘酚12份,甲基硅烷醇轻脯氨酸酯天冬氨酸酯9份,维生素A酸9份,胶原蛋白13份,维生素C4份,维生素E 4份,羟甲基纤维素钠4份,丙三醇13份,黄原胶2份,羟基乙酸4份,薄荷冰2份。
为了证明本发明主要活性成分的协同效果,以实施例一为基础,提供以下对比实施例及临床效果。
对比例一
一种消除妊娠纹的护肤膏,由重量份数的原料制成:表皮细胞生长因子10份,山维生素C 3份,维生素E 3份,羟甲基纤维素钠3份,丙三醇10份,黄原胶1份,羟基乙酸3份,薰衣草精油1份,薄荷冰1份。
以上产品经临床30名受试者使用,受试者选取分娩后3月-36月的女性,于早晚各使用一次,使用方法为将0.5克护肤膏均匀涂抹在妊娠纹或皮肤皱纹处,一个月为一疗程。其中,其中,2个受试者使用六个疗程后基本消除了妊娠纹,4个受试者使用十二个疗程后基本消除了妊娠纹,14个受试者使用十二个疗程后妊娠纹无改善。。
对比例二
一种消除妊娠纹的护肤膏,由重量份数的原料制成:山萘酚10份,维生素C 3份,维生素E 3份,羟甲基纤维素钠3份,丙三醇10份,黄原胶1份,羟基乙酸3份,薰衣草精油1份,薄荷冰1份。
以上产品经临床30名受试者使用,受试者选取分娩后3月-36月的女性,于早晚各使用一次,使用方法为将0.5克护肤膏均匀涂抹在妊娠纹或皮肤皱纹处,一个月为一疗程。其中,其中,6个受试者使用六个疗程后基本消除了妊娠纹,8个受试者使用十二个疗程后基本消除了妊娠纹,6个受试者使用十二个疗程后妊娠纹无改善。。
对比例三
一种消除妊娠纹的护肤膏,由重量份数的原料制成:甲基硅烷醇轻脯氨酸酯天冬氨酸酯5份,维生素C 3份,维生素E 3份,羟甲基纤维素钠3份,丙三醇10份,黄原胶1份,羟基乙酸3份,薰衣草精油1份,薄荷冰1份。
以上产品经临床30名受试者使用,受试者选取分娩后3月-36月的女性,于早晚各使用一次,使用方法为将0.5克护肤膏均匀涂抹在妊娠纹或皮肤皱纹处,一个月为一疗程。其中,其中,2个受试者使用六个疗程后基本消除了妊娠纹,9个受试者使用十二个疗程后基本消除了妊娠纹,9个受试者使用十二个疗程后妊娠纹无改善。
对比例四
一种消除妊娠纹的护肤膏,由重量份数的原料制成:维生素A酸5份,维生素C 3份,维生素E 3份,羟甲基纤维素钠3份,丙三醇10份,黄原胶1份,羟基乙酸3份,薰衣草精油1份,薄荷冰1份。
以上产品经临床30名受试者使用,受试者选取分娩后3月-36月的女性,于早晚各使用一次,使用方法为将0.5克护肤膏均匀涂抹在妊娠纹或皮肤皱纹处,一个月为一疗程。其中,11个受试者使用六个疗程后基本消除了妊娠纹,2个受试者使用十二个疗程后基本消除了妊娠纹,7个受试者使用十二个疗程后妊娠纹无改善。
对比例五
一种消除妊娠纹的护肤膏,由重量份数的原料制成:胶原蛋白10份,维生素C 3份,维生素E 3份,羟甲基纤维素钠3份,丙三醇10份,黄原胶1份,羟基乙酸3份,薰衣草精油1份,薄荷冰1份。
以上产品经临床30名受试者使用,受试者选取分娩后3月-36月的女性,于早晚各使用一次,使用方法为将0.5克护肤膏均匀涂抹在妊娠纹或皮肤皱纹处,一个月为一疗程。其中,使用十二个疗程后无受试者的妊娠纹有减轻或消除。
Claims (6)
1.一种消除妊娠纹的护肤膏,其特征在于,包含以下重量份数的原料:表皮细胞生长因子10-15份,山萘酚10-15份,甲基硅烷醇羟脯氨酸酯天冬氨酸酯5-10份,维生素A酸5-10份,胶原蛋白10-15份。
2.根据权利要求1所述的消除妊娠纹的护肤膏,其特征在于,包含以下重量份数的原料:表皮细胞生长因子10-12份,山萘酚10-12份,甲基硅烷醇羟脯氨酸酯天冬氨酸酯8-10份,维生素A酸8-10份,胶原蛋白12-15份。
3.根据权利要求1或2所述的消除妊娠纹的护肤膏,其特征在于,还包括以下重量份数的原料:维生素C 3-5份,维生素E 3-5份,羟甲基纤维素钠3-5份,丙三醇10-15份,黄原胶1-3份,羟基乙酸3-5份。
4.根据权利要求1或2所述的消除妊娠纹的护肤膏,其特征在于,还包括以下重量份数的原料:薰衣草精油1-5份,薄荷冰1-5份。
5.根据权利要求1或2所述的消除妊娠纹的护肤膏,其特征在于,所述维生素A酸为全反式维生素A酸。
6.根据权利要求1或2所述的消除妊娠纹的护肤膏,其特征在于,所述胶原蛋白为水解胶原蛋白。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610738211.4A CN106344435A (zh) | 2016-08-26 | 2016-08-26 | 消除妊娠纹的护肤膏 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610738211.4A CN106344435A (zh) | 2016-08-26 | 2016-08-26 | 消除妊娠纹的护肤膏 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106344435A true CN106344435A (zh) | 2017-01-25 |
Family
ID=57855300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610738211.4A Pending CN106344435A (zh) | 2016-08-26 | 2016-08-26 | 消除妊娠纹的护肤膏 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106344435A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107375030A (zh) * | 2017-08-02 | 2017-11-24 | 苏州爱喜邦物联网科技有限公司 | 一种消除妊娠纹的护肤膏 |
CN108175740A (zh) * | 2018-01-29 | 2018-06-19 | 广州好润生物科技有限公司 | 一种具有有效预防及祛除妊娠纹功效的修复霜及其制备方法 |
CN110013447A (zh) * | 2019-03-13 | 2019-07-16 | 广州雅纯化妆品制造有限公司 | 一种祛除妊娠纹的膏霜及其制备方法 |
CN111514082A (zh) * | 2020-05-14 | 2020-08-11 | 深圳爱思得美容科技有限公司 | 一种妊娠纹修复组合物及其应用方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101111244A (zh) * | 2004-12-31 | 2008-01-23 | 株式会社太平洋 | 含有山奈酚和槲皮素的透明质酸生成促进用组合物 |
CN103006491A (zh) * | 2011-09-23 | 2013-04-03 | 深圳市金因生物技术有限公司 | 一种祛除生长纹的生物护肤制品及其制备方法 |
CN104586641A (zh) * | 2014-11-06 | 2015-05-06 | 苏州华莃药业有限公司 | 一种抗皮肤衰老的高效复方药及其制备方法 |
-
2016
- 2016-08-26 CN CN201610738211.4A patent/CN106344435A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101111244A (zh) * | 2004-12-31 | 2008-01-23 | 株式会社太平洋 | 含有山奈酚和槲皮素的透明质酸生成促进用组合物 |
CN103006491A (zh) * | 2011-09-23 | 2013-04-03 | 深圳市金因生物技术有限公司 | 一种祛除生长纹的生物护肤制品及其制备方法 |
CN104586641A (zh) * | 2014-11-06 | 2015-05-06 | 苏州华莃药业有限公司 | 一种抗皮肤衰老的高效复方药及其制备方法 |
Non-Patent Citations (2)
Title |
---|
叶翔: "硅烷醇在妊娠纹治疗中的作用", 《中国化妆品(行业)》 * |
无: "外涂柠檬汁可除妊娠纹", 《中医健康养生》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107375030A (zh) * | 2017-08-02 | 2017-11-24 | 苏州爱喜邦物联网科技有限公司 | 一种消除妊娠纹的护肤膏 |
CN108175740A (zh) * | 2018-01-29 | 2018-06-19 | 广州好润生物科技有限公司 | 一种具有有效预防及祛除妊娠纹功效的修复霜及其制备方法 |
CN110013447A (zh) * | 2019-03-13 | 2019-07-16 | 广州雅纯化妆品制造有限公司 | 一种祛除妊娠纹的膏霜及其制备方法 |
CN110013447B (zh) * | 2019-03-13 | 2022-08-05 | 广州雅纯化妆品制造有限公司 | 一种祛除妊娠纹的膏霜及其制备方法 |
CN111514082A (zh) * | 2020-05-14 | 2020-08-11 | 深圳爱思得美容科技有限公司 | 一种妊娠纹修复组合物及其应用方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101678621B1 (ko) | 스피큘을 포함하는 피부관리용 화장품 조성물 및 이의 제조방법 | |
CN101791283B (zh) | 一种可消除妊娠纹和疤痕的化妆品 | |
CN104644523B (zh) | 一种医用生物除皱抑斑敷料及其制备方法 | |
JP2003517858A (ja) | 老齢関連の軟組織の欠陥の増強と修復 | |
CN104921983A (zh) | 一种孕妇妊娠纹医用生物修复敷料及其制备方法 | |
CN103908424A (zh) | 一种用于美容保养的精华液及其制备方法 | |
CN102085172B (zh) | 一种以美洲荻尾草提取物为主要组分的护肤化妆品及其制备方法 | |
CN106344435A (zh) | 消除妊娠纹的护肤膏 | |
CN108743921A (zh) | 一种预防疤痕形成的修复液及其制备方法和应用 | |
CN108175740B (zh) | 一种具有有效预防及祛除妊娠纹功效的修复霜及其制备方法 | |
CN109745618A (zh) | 一种妊娠纹的修复方法 | |
CN105013019A (zh) | 一种组织工程全层皮肤及其制备方法 | |
KR20180134468A (ko) | 스피큘과 해양콜라겐 및 해양심층수를 포함하는 해양 화장품 조성물 및 이의 제조방법 | |
CN105749333B (zh) | 一种透明质酸医用敷料及其制备方法 | |
CN105056307A (zh) | 一种人造皮肤及其制备方法 | |
CN103520017A (zh) | 一种除皱抗衰、活化肌肤、修复美白的组合物 | |
CN109646459A (zh) | 一种水光注射仪注射脐带间充质干细胞制剂及其应用 | |
CN104740677A (zh) | 一种皮肤医用修复敷料及其制备方法 | |
CN113332193A (zh) | 一种预防妊娠纹的组合物和按摩霜 | |
Wysocki | A review of the skin and its appendages | |
CN103656751A (zh) | ADM-bFGF复合体及运用 | |
KR20120140450A (ko) | 인간 중간엽줄기세포의 분화 촉진용 조성물 | |
CN101057823B (zh) | 一种具有抗衰老及美容作用的复合生物制剂 | |
CN119606928B (zh) | 一种复合营养素微针生发贴及其应用 | |
CN113520991B (zh) | 一种阻断瘢痕形成与逆向修复调节的纳米生物凝胶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170125 |